Thermo Fisher Scientific Inc.

NYSE:TMO Stock Report

Market Cap: US$159.9b

Thermo Fisher Scientific Future Growth

Future criteria checks 1/6

Thermo Fisher Scientific is forecast to grow earnings and revenue by 10.1% and 5.1% per annum respectively. EPS is expected to grow by 10.6% per annum. Return on equity is forecast to be 17.1% in 3 years.

Key information

10.1%

Earnings growth rate

10.6%

EPS growth rate

Life Sciences earnings growth16.1%
Revenue growth rate5.1%
Future return on equity17.1%
Analyst coverage

Good

Last updated02 May 2025

Recent future growth updates

Recent updates

Thermo Fisher Scientific: Tariff And Policy Impacts Look Priced In

Apr 24

Thermo Fisher Scientific And Its Real Value

Apr 14
author-image

The demand for personalized medicine will keep Thermo Fisher Scientific thriving

Mar 18Resilient Demand for Life Sciences & Diagnostics – TMO is a key supplier for biotech, pharma, and research institutions, ensuring steady demand despite economic cycles.

Thermo Fisher Scientific: Strong Q4, Strategic M&A, And Poised For Growth In Life Sciences

Mar 07

Earnings Preview: Thermo Fisher Is Facing Way Too Many Headwinds

Jan 29

Biologicals Is The Future In Thermo Fisher: Buy Rating

Jan 22

An Intrinsic Calculation For Thermo Fisher Scientific Inc. (NYSE:TMO) Suggests It's 31% Undervalued

Jan 18
An Intrinsic Calculation For Thermo Fisher Scientific Inc. (NYSE:TMO) Suggests It's 31% Undervalued

Does Thermo Fisher Scientific (NYSE:TMO) Have A Healthy Balance Sheet?

Dec 31
Does Thermo Fisher Scientific (NYSE:TMO) Have A Healthy Balance Sheet?

Thermo Fisher Scientific Inc.'s (NYSE:TMO) Share Price Not Quite Adding Up

Dec 13
Thermo Fisher Scientific Inc.'s (NYSE:TMO) Share Price Not Quite Adding Up

Thermo Fisher Scientific: Renewed Growth Momentum After The Pandemic

Dec 10

Thermo Fisher: M&A And Innovation To Drive Sales Growth

Dec 04

Thermo Fisher Scientific: Near The Bottom And Attractively Valued

Nov 14

Thermo Fisher Scientific Q3: Expecting Market Recovery In FY25; Upgrade To 'Buy'

Oct 23

Thermo Fisher Scientific: Fantastic Company, Rich Valuation

Oct 04

These 4 Measures Indicate That Thermo Fisher Scientific (NYSE:TMO) Is Using Debt Reasonably Well

Sep 21
These 4 Measures Indicate That Thermo Fisher Scientific (NYSE:TMO) Is Using Debt Reasonably Well

Thermo Fisher Scientific Inc.'s (NYSE:TMO) Price Is Out Of Tune With Earnings

Aug 16
Thermo Fisher Scientific Inc.'s (NYSE:TMO) Price Is Out Of Tune With Earnings

Thermo Fisher Scientific: Microscopic Signs Of Growth Emerging

Jul 25

A Look At The Fair Value Of Thermo Fisher Scientific Inc. (NYSE:TMO)

Jul 11
A Look At The Fair Value Of Thermo Fisher Scientific Inc. (NYSE:TMO)

Is Thermo Fisher Scientific (NYSE:TMO) A Risky Investment?

Jun 18
Is Thermo Fisher Scientific (NYSE:TMO) A Risky Investment?

Low Yield, High Growth: Unveiling The Power Of Thermo Fisher's Dividends

Jun 07

Thermo Fisher: Renewed Growth Yet To Materialize, But Already Priced In (Rating Downgrade)

Apr 30

Earnings and Revenue Growth Forecasts

NYSE:TMO - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202749,5648,5169,07310,65620
12/31/202646,4077,4678,6039,98028
12/31/202543,6816,5817,3398,61128
3/29/202542,8986,5146,7248,139N/A
12/31/202442,8796,3357,2678,667N/A
9/28/202442,3706,1357,7759,100N/A
6/29/202442,3466,2207,9639,348N/A
3/30/202442,4926,0347,5608,928N/A
12/31/202342,8575,9956,9278,406N/A
9/30/202343,4215,9416,5468,170N/A
7/1/202343,5245,7215,8547,693N/A
4/1/202343,8076,0245,6207,681N/A
12/31/202244,9156,9506,9119,154N/A
10/1/202244,1677,0325,6008,124N/A
7/2/202242,8207,4396,3368,837N/A
4/2/202241,1237,6037,0019,536N/A
12/31/202139,2117,7256,7899,312N/A
10/2/202139,0598,5657,91610,194N/A
7/3/202138,2508,5968,13210,252N/A
4/3/202135,8947,9248,0629,911N/A
12/31/202032,2186,3756,8158,289N/A
9/26/202028,4974,8795,6866,863N/A
6/27/202026,2483,7064,2455,272N/A
3/28/202025,6473,6693,7024,680N/A
12/31/201925,5423,6964,0474,973N/A
9/28/201925,2203,5923,9404,861N/A
6/29/201924,8683,5414,0864,964N/A
3/30/201924,6303,1744,2735,114N/A
12/31/201824,3582,938N/A4,543N/A
9/29/201823,8982,570N/A4,608N/A
6/30/201823,0942,395N/A4,317N/A
3/31/201822,0062,256N/A3,722N/A
12/31/201720,9182,228N/A4,005N/A
9/30/201719,8242,330N/A3,344N/A
7/1/201719,1992,270N/A3,220N/A
4/1/201718,7442,174N/A3,284N/A
12/31/201618,2742,025N/A3,258N/A
10/1/201617,9731,999N/A3,281N/A
7/2/201617,6062,003N/A3,220N/A
4/2/201617,3411,998N/A3,072N/A
12/31/201516,9651,980N/A2,942N/A
9/26/201516,8061,978N/A2,543N/A
6/27/201516,8541,971N/A2,475N/A
3/28/201516,9051,738N/A2,598N/A
12/31/201416,8901,896N/A2,620N/A
9/27/201415,8641,635N/A2,394N/A
6/28/201414,8841,482N/A2,224N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: TMO's forecast earnings growth (10.1% per year) is above the savings rate (2.8%).

Earnings vs Market: TMO's earnings (10.1% per year) are forecast to grow slower than the US market (13.9% per year).

High Growth Earnings: TMO's earnings are forecast to grow, but not significantly.

Revenue vs Market: TMO's revenue (5.1% per year) is forecast to grow slower than the US market (8.5% per year).

High Growth Revenue: TMO's revenue (5.1% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: TMO's Return on Equity is forecast to be low in 3 years time (17.1%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/04 10:56
End of Day Share Price 2025/05/02 00:00
Earnings2025/03/29
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Thermo Fisher Scientific Inc. is covered by 53 analysts. 28 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kadambari DaptardarAccountability Research Corporation
David ToungArgus Research Company
Catherine Ramsey SchulteBaird